# Gut Microbiota and Glioblastoma Multiforme Prognosis

> **NCT03631823** · — · UNKNOWN · sponsor: **Huashan Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Gut Microbiota, Glioblastoma Multiforme, Microglia, Tumor Related Macrophagocyte, Prognosis

## Interventions

- **OTHER:** Chemotherapy with temozolomide or no chemotherapy

## Key facts

- **NCT ID:** NCT03631823
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-10
- **Primary completion:** 2019-08-10
- **Final completion:** 2020-05-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03631823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03631823, "Gut Microbiota and Glioblastoma Multiforme Prognosis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03631823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*